NPPA and myeloid sarcoma: Disease progression brings about a change in KP profile and the chronic activation of the enzymes involved in the pathway enhances the production of neurotoxic metabolites and thus contributes to the emergence of progression in MS (Lim et al., 2010, 2017; Lovelace et al., 2016).